Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell linesRieko Oyama(Juntendo University), Tadashi Kondo(National Cancer Research Institute)Scientific ReportsJune 29, 201710.1038/s41598-017-04967-0Cited by 58SaveCiteExport RISWatch citationsRelated PapersClinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating Cells|Stem Cells|2013|72Decorin as a prognostic biomarker in patients with malignant peripheral nerve sheath tumors|Oncology Letters|2019|8